If you plan to attend, please call the department to verify date/time/room, since changes still may occur.

  • Lerner Research Institute: (216) 444-3900
  • Anesthesiology Research: (216) 444-0543
  • Biomedical Engineering: (216) 445-6980
  • Cancer Biology: (216) 445-7434
  • Cell Biology: (216) 444-8359
  • Immunology: (216) 444-1272
  • Integrative Medicine: (216) 445-9143
  • Molecular Biology: (216) 444-0629
  • Molecular Cardiology: (216) 445-8200
  • Neurosciences: (216) 444-7177
  • Neurosurgery: (216) 444-7591
  • Ophthalmic Research: (216) 444-5832
  • Orthopaedic Research Center: (216) 445-2028
  • Orthopaedic Surgery: (216) 445-7570
  • Research Education Office: (216) 445-6690
  • Stem Cell Biology: (216) 444-3900
  • Surgery Research: (216) 445-3800
  • Taussig Cancer Center: (216) 444-7924
  • Virology: (216) 445-1203
  • Case Comprehensive Cancer Center: (216) 368-1177

Research Seminars & Events

Wed
1
Sep. 1, 12:00pm-1:00pm, NC1-202:
The Kinase Activity of IKKi is Required for IL-17-induced mRNA Stabilization of Inflammatory Genes, Katarzyna Bulek, Ph.D. Post Doctoral Fellow, Li Lab
» More
Ritika Jaini, Ph.D. Research Associate, Tuohy Lab Autoimmune Mediated Breast Cancer Vaccination
Sep. 1, 3:30pm-4:30pm, NC1-202:
TO BE ANNOUNCED, MOLECULAR CARDIOLOGY FACULTY SEMINAR SERIES: Nicolay Malinin, Ph.D.
Wed
8
Sep. 8, 3:30pm-4:30pm, NC1-202:
TO BE ANNOUNCED, MOLECULAR CARDIOLOGY FACULTY SEMINAR SERIES; Jane Hoover-Plow, Ph.D.
Fri
10
Sep. 10, 8:00am-9:00am, R3-002/003:
Early Detection of Cardiotoxicity, Taussig Cancer Institute Grand Rounds: Juan Carlos Plana, MD., Cleveland Clinic, Cleveland, OH
Wed
15
Sep. 15, 12:00pm-1:00pm, NC1-202:
T Cell Adoptive Immunotherapy of HER2+ Breast Cancer, Greg Plautz, M.D., Departments of Pediatric Hematology/Oncology and Immunology
Sep. 15, 4:30pm-5:30pm, NE1-205:
LRI Showcase Seminar "Myosin II motor proteins: Cytoskeletal roles in cancer cell migration and skin wound healing", Thomas Egelhoff, PhD
Fri
17
Sep. 17, 8:00am-9:00am, R3-002/003:
Current Lung Cancer Research within the RTOG, Taussig Cancer Institute Grand Rounds: Jeffrey Bradley, MD., Siteman Cancer Center, St. Louis, MO.
Sep. 17, 10:00am-11:00am, NC1-202:
TBA, Ofer Reizes, Ph.D., Associate Staff, Cell Biology, LRI
Tue
21
Sep. 21, 12:00pm-1:00pm, R3-002:
Follicular Lymphoma, Taussig Cancer Institute Core Curriculum: Stephen Smith, MD
Wed
22
Sep. 22, 12:00pm-1:00pm, NC1-202:
Memory CD4 T Cells and Alloantibody Production This is a promotion seminar. All are invited to attend., Anna Valujskikh, Ph.D. Assistant Staff, Department of Immunology
Fri
24
Sep. 24, 8:00am-9:00am, R3-002/003:
Personalized Therapeutics Using Gene Based Technology, Taussig Cancer Institute Grand Rounds: John Nemunaitis, MD., Mary Crowley Cancer Research Center, Dallas, TX.
Sep. 24, 10:00am-11:00am, NE1-205:
Hyperglycemic dividing cells initiate intracellular synthesis of hyaluronan that drives autophagy and formation of a monocyte-adhesive extracellular matrix, Vincent Hascall, Ph.D., Staff, Biomedical Engineering, LRI
Mon
27
Sep. 27, 8:00am-6:30pm, Geneva State Park Conference Center, Geneva, Ohio:
LRI Annual Retreat, New LRI Faculty talks
» More

Dinner speaker will be Dr. Mukesh Jain, Director, Case Cardiovascular Research Institute

Tue
28
Sep. 28, 12:00pm-1:00pm, R3-002:
Lung Cancer - Part II, Taussig Cancer Institute Core Curriculum: Abdo Haddad, MD
Wed
29
Sep. 29, 12:00pm-1:00pm, NC1-202:
Regulation of Cell Fate and Development by Glycogen Synthase Kinase-3, James Woodgett, Ph.D., Director of Research, Samuel Lunenfeld Research Institute, Toronto, Canada